When the "safe" pathways in the liver become overwhelmed, more of the medication is pushed through the pathway that creates NAPQI
Injectable Dose: 0.1 to 0.2 mg three times weekly Topical Option: Apply serum to target areas twice daily Combined Approach: Injectable 3x weekly plus topical to specific areas Duration: 8 to 12 weeks, can extend longer due to favorable safety profile The timing of GHK-Cu introduction matters for maximum benefit
Is GHK-CU safe for long-term use
In some cases, adjustments to infusion ingredients or hydration levels may be recommended
The contribution of nAb effector functions tends to be greater during established infection than during prophylaxis
Sathiyamoorthy, K., Mills, E., Franzmann, T